1790Targeting filarial kinases with human homologues: repurposed, orally available, approved tyrosine kinase inhibitors (TKI) act as micro- and macrofilaricidal agents at concentrations easily achievable in vivo
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.